Johnson & Johnson Development Corporation (JJDC) is the strategic venture capital division of Johnson & Johnson. They focus their investments across pharmaceutical, medical devices and consumer healthcare sectors at all stages. Their investments take a long-term approach in which they use the resources of Johnson & Johnson to support their companies, which includes discovery, clinical development, regulatory affairs, manufacturing and commercialization.
They exited their investments in NovoCure, Nevro, Inspire Medical Systems, Biocartis, Mazor Robotics, Aduro BioTech, PowerVision, Neotract, Genocea Biosciences, Merus, PhaseBio Pharmaceuticals and Protagonist Therapeutics.
A biopharmaceutical company developing T cell vaccines and immunotherapies
Rodin Therapeutics is a biotechnology company developing treatments for Alzheimer's disease that is headquartered in Cambridge, Massachusetts and was founded in 2013 by Ankit Mahadevia and Martin Jefson.
Catalyst Biosciences is a clinical development biopharmaceutical and research company.
Nevro is a biotechnology company.
A clinical cancer genomics company using liquid biopsy in cancer patients
Celladon is a biotechnology company that focuses in the development of molecular therapies to treat heart failure.
Aduro Biotech is a biotechnology company.
Mazor Robotics is a Caesarea-based company founded in 2001 by Eli Zehavi.
Axial Biotech is a company developing genetic tests and treatment solutions for spinal disorders.
Binx Health Limited is a developer of point-of-care testing platforms.
A biopharmaceutical company that develops drugs for the treatment of cardiovascular diseases, endocrine and other metabolic disorders
Intio is a Broomfield, Colorado-based diagnostic tools company focused on diagnostics for oncology.
Mitralign is a Tewksbury, Massachusetts-based company.
Aro Biotherapeutics is a Philadelphia County, Pennsylvania-based company.
Asish K. Xavier
V. Kadir Kadhiresan